Aptar Pharma’s e-Lockout has both locking and child resistant features for safe and compliant nasal drug delivery. E-lockout monitors the amount and timing of drug delivered, can improve patient compliance, and help prevent overdosing of potent drugs. Our e-Lockout is approved by the European Medicines Agency (EMA).Download Aptar Pharma Overview Brochure
The Smart Electronic Device with Locking Features
Ensures safe and compliant drug delivery
Our e-Lockout device can help ensure safe and compliant drug delivery by limiting the number of doses available during a 24-hour period. Its built-in locking mechanism prevents the device from being used for a period of time after a pre-defined number of spray actuations.
Additionally, the electronic display shows the number of priming strokes, the number of doses remaining in the device, time remaining until the next dose, and whether the nasal spray is locked or ready for use.
Our e-Lockout can also incorporate specific warning features to remind patients to take their medications so that they are fully compliant in their treatment. Other features include a child-resistant cap.
Our advanced patented electronic technology may be useful in drug delivery treatment for diseases involving acute episodes, such as breakthrough pain.
Validated technology approved by the European Medicines Agency
Our e-Lockout technology is the only fully integrated electronic nasal drug delivery device to be approved by the European Medicines Agency (EMA).
Designed with patient safety in mind as well as ease of use, reliability and accuracy, our e-Lockout technology complies with the most stringent regulatory guidance.
Our device is tamper-proof, which is an important feature with controlled substances and for managing breakthrough pain.
- Built in Locking Mechanism
- Simple Electronic Display
- Child-Resistant Cap
- Patented Electronic Technology
- Customization According to Your Needs
Helps ensure patient safety
The built in locking mechanism prevents the device from being used after a pre-defined number of spray actuations, thus ensuring patient safety while administering potent drug products in a multidose format. In addition to safety, the locking mechanism can help patient compliance in chronic or acute conditions, especially in break though pain.
Reliable and reassuring for patients
The simple and easy to read electronic display shows the number of doses left, the remaining time for the next dose, and whether the nasal spray is locked or ready to use.
These reliable and patient-friendly features can be reassuring for patients.
Tamper proof opening to prevent misuse
The child-resistant cap prevents misuse by children.
Fully integrated within the device
Our patented e-Lockout technology is fully integrated into the device for safe and compliant treatment of chronic conditions.
Let us help you develop your next safe solution
Our e-Lockout can be customized according to your needs, such as dosing needs (time between doses, dose volume) and electronic features. Our electronic locking technology can be applied to other delivery routes, such as oral sprays, for example. We’d love to help you develop your next safe solution.
Another Proven Solution For Safe Nasal Drug Delivery
As global leaders in proven nasal drug delivery solutions, we can help you develop safe solutions for patients. Why not speak to one of our experts today?
Request More Information
Requesting information on e-Lockout.